2017
DOI: 10.1016/j.nephro.2017.01.013
|View full text |Cite
|
Sign up to set email alerts
|

Prospective : comment traitera-t-on les tumeurs rénales et prostatiques et urothéliales dans 10 ans ?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 72 publications
0
1
0
Order By: Relevance
“…Prostate cancer (PC) is the most common noncutaneous cancer in men and the third most common cause of cancer-related death in males residing in the USA and the UK [18]. Newly diagnosed individuals with localized PC have a high 10-year survival rate and a high chance of complete recovery whereas men with metastatic “aggressive” forms of PC tend to have much poorer outcomes [19, 20]. The molecular and cellular mechanisms of initiation, progression, and outcomes of PC are poorly understood.…”
Section: Discussionmentioning
confidence: 99%
“…Prostate cancer (PC) is the most common noncutaneous cancer in men and the third most common cause of cancer-related death in males residing in the USA and the UK [18]. Newly diagnosed individuals with localized PC have a high 10-year survival rate and a high chance of complete recovery whereas men with metastatic “aggressive” forms of PC tend to have much poorer outcomes [19, 20]. The molecular and cellular mechanisms of initiation, progression, and outcomes of PC are poorly understood.…”
Section: Discussionmentioning
confidence: 99%